ArticleCancer medicine2019

Durable response for ampullary and duodenal adenocarcinoma with a nab-paclitaxel plus gemcitabine ± cisplatin combination.

Putao Cen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.